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HIGHLIGHTS 
-Updated literature overview about probiotics, prebiotics and synbiotics on pig gut health is 
provided 
-Both in vivo studies performed in pigs and in vitro studies conducted in pig intestinal cell lines are 
described 
-A critical outcome of the described results is provided 
-The concept of “proxy measurements” for pig gut health is widely discussed 
-The link between gut microbiota and mucsal immune system is described 
 
Abstract: 
Probiotics are live microorganisms that can confer a health benefit on the host, and amongst various 
mechanisms probiotics are believed to exert their effects by production of antimicrobial substances, 
competition with pathogens for adhesion sites and nutrients, enhancement of mucosal barrier 
integrity and immune modulation. Through these activities probiotics can support three core 
benefits for the host: supporting a healthy gut microbiota, a healthy digestive tract and a healthy 
immune system. More recently, the concept of combining probiotics and prebiotics, i.e. synbiotics, 
for the beneficial effect on gut health of pigs has attracted major interest, and examples of probiotic 
and prebiotic benefits for pigs are pathogen inhibition and immunomodulation. Yet, it remains to be 
defined in pigs, what exactly is a healthy gut. Because of the high level of variability in growth and 
feed conversion between individual pigs in commercial production systems, measuring the impact 
of probiotics on gut health defined by improvements in overall productivity requires large 
experiments. For this reason, many studies have concentrated on measuring the effects of the feed 
additives on proxies of gut health including many immunological measures, in more controlled 
experiments. With the major focus of studying the balance between gut microbiology, immunology 
and physiology, and the potential for prevention of intestinal disorders in pigs, we therefore 
performed a literature review of the immunomodulatory effects of probiotics, either alone or in 
combination with prebiotics, based on in vivo, in vitro and ex vivo porcine experiments. A 
3 
 
consistent number of studies showed the potential capacity in terms of immunomodulatory activities 
of these feed additives in pigs, but contrasting results can also be obtained from the literature. 
Reasons for this are not clear but could be related to differences with respect to the probiotic strain 
used, experimental settings, diets, initial microbiota colonization, administration route, time and 
frequency of administration of the probiotic strain and sampling for analysis. Hence, the use of 
proxy measurements of enteric health based on observable immunological parameters presents 
significant problems at the moment, and cannot be considered robust, reliable predictors of the 
probiotic activity in vivo, in relation to pig gut health. In conclusion, more detailed understanding of 
how to select and interpret these proxy measurements will be necessary in order to allow a more 
rational prediction of the effect of specific probiotic interventions in the future.  
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Abbreviations list: 
CFU, colony forming units; EPS, extracellular polysaccharide; GIT, gastrointestinal tract; GM-
CSF, granulocyte macrophage colony-stimulating factor; ETEC, enterotoxigenic E. coli; FOS, 
fructo-oligosaccharide; GOS, galacto-oligosaccharide; HSP, heat shock protein; IPEC-1, intestinal 
porcine epithelial cells-1; IPEC-J2, intestinal porcine epithelial cells-2J, IPI-2I, ileal porcine 
intestinal-2I; LGG, Lactobacillus rhamnosus GG; LPS, lipopolysaccharide; MAPK, mitogen-
activated protein kinase; MCP-1, monocyte chemoattractant protein-1; PIE, porcine intestinal 
epitheliocyte; RV, Rotavirus; SCFA, short chain fatty acids; TEER, transepithelial electrical 
resistance; TNF-α, tumor necrosis factor-α; Tregs, regulatory T-cells; VSV, vesicular stomatitis 
virus; ZO-1, zonula occludens-1. 
 
 
1. Introduction 
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The value of dietary modulation and nutritional strategies to enhance gut health of pigs is becoming 
increasingly apparent. While a frequently used term in relation to human and animal health, the 
precise scientific definition of ‘gut health’ is still lacking. An absolute state of optimal gut health is 
probably practically impossible to define, as gut health is a dynamic and relative concept. Bischoff 
(2011) proposed five major criteria for a healthy gastrointestinal tract in humans, being: 1) effective 
digestion and absorption of food, 2) absence of gastrointestinal illness, 3) normal and stable 
intestinal microbiota, 4) effective immune status, and 5) a status of well-being. However, it is worth 
noting that many of the terms used (‘effective’, ‘normal’, ‘well-being’) are, in themselves, relative 
terms and difficult to define. A definition of a healthy gut has to be accompanied by a measure of 
the overall health and welfare of the animal. Whereas the interest in immune modulation in relation 
to human gut health has primarily addressed severe inflammatory diseases such as inflammatory 
bowel disease and colon cancer, the focus of pig gut health has been both in relation to prevention 
of infectious diseases and performance of the animals, i.e. nutrient utilization and growth 
performance (Heo et al. 2013; Pieper et al. 2016). Weaned piglets commonly suffer from 
gastroenteritis caused by enterotoxigenic Escherichia coli (ETEC). The European legislation has 
banned the use of in-feed antibiotics as growth promoters since 2006, and the high reduction of 
antibiotics use has been shown to be effective in limiting the prevalence of antibiotic resistance 
genes in the gut microbiota of European pigs compared to Chinese pigs (Xiao et al. 2016). 
However, the use of sub-therapeutic antibiotics for prevention of enteric diseases among weaning 
pigs has continued the concerns regarding the increasing emergence of antibiotic resistant bacteria. 
There is still a demand for the development of alternatives to antibiotics while preserving health in 
farm systems. Probiotics, especially, have been primarily used as feed-additives to prevent 
infectious intestinal diseases and to improve performance of livestock (Guo et al. 2006). In their 
review, Lalles et al. (2007) concluded that manipulation of the prebiotic composition of the 
weaning diet may be the most promising way to improve gut health in weaned piglets, and that 
positive results have also been produced with probiotics fed to piglets or to sows. The major 
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responses appeared to be mediated through early changes in the gastrointestinal microbiota, 
including enhanced number of beneficial bacteria and/or decreased number of potentially 
pathogenic bacteria together with favorable fermentation products. Measureable, reproducible 
effects of dietary pre- and probiotics on intestinal physiology and mucosal immunology were 
limited or difficult to interpret (Lalles et al. 2007). However, subsequent and more recent studies 
have been conducted with probiotics to study the effect on intestinal immune responses under 
challenge of the pigs (e.g. Yang et al. 2016), and more scientific knowledge is available on the 
fundamental mechanisms of the potential immunomodulatory effects of the feed additives. 
The purpose of the present paper was to review the literature in order to synthesize the knowledge 
concerning the immune modulating effects and mechanisms of action of probiotics, either alone or 
in combination with prebiotics in relation to gut health, with special emphasis on the fine balance 
between gut microbiology, immunology and physiology, and the potential prevention of intestinal 
disorders in pigs. In vitro (intestinal pig cell lines) and in vivo investigations on pigs were 
considered in the literature search. General criteria of including peer-reviewed journal articles in 
English and selectively including book articles or chapters, as well as grey literature such as PhD 
theses and dissertations were used. 
 
2. Definitions 
   The widely accepted definition of probiotics was formulated by a FAO/WHO Commission of 
experts in 2001: “live microorganisms that, when administered in adequate amounts, confer a health 
benefit on the host” (FAO/WHO, 2001). Most of the species ascribed as having probiotic properties 
belong to the genera Lactobacillus and Bifidobacterium, commonly found in the gastrointestinal 
tract (GIT) of humans and animals and thus generally regarded as safe. However, also members of 
other bacterial genera can have probiotic activity, indeed most of the probiotic strains used in pig 
farms belong to Bacillus, Enterococcus and Saccaromyces genera.  Such strains are selected mainly 
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on the basis of their good producibility on larger scales and high viability and stability during 
storage and feed preparation (Ohashi and Ushida, 2009). 
Amongst various possible mechanisms of action, probiotics are believed to exert their effects by 
production of antimicrobial substances, competition with pathogens for adhesion sites and nutrients, 
enhancement of mucosal barrier integrity and immune modulation (O’Hara and Shanahan, 2007; 
Bermudez-Brito et al., 2012).Thus, the beneficial activities of probiotics are ascribable to three 
main core benefits: supporting a healthy gut microbiota, a healthy digestive tract and a healthy 
immune system (Hill et al. 2014). 
 It is widely recognized that the health benefits of probiotics are highly strain-specific, thus different 
strains belonging to the same species can have different effects. For such reason, multi-strain 
mixtures may be more effective than single strains by complementing each other’s health effects 
and exerting synergistic activities (Timmerman et al. 2004).   Prebiotics are “non-digestible food 
ingredients that beneficially affect the host by selectively stimulating the growth and/or activity of 
one or a limited number of bacteria in the colon that have the potential to improve host health” 
(Gibson and Roberfroid, 1995). Prebiotics can also be fermented in pig large intestine (Jensen, 
1998). From that derives the capacity of prebiotics to positively modulate the composition and/or 
activity of gut microbiota that confer benefits upon host wellbeing and health (Gibson, 2004, 
Gibson et al. 2010). The most commonly used prebiotics are galacto-oligosaccharides (GOS), inulin 
and fructooligosaccharides (FOS), which are plant storage carbohydrates in vegetables, cereals and 
fruits (Macfarlane et al. 2008). By the early 2000s, the development of next generation, rationally 
selected prebiotics was proposed (Rastall and Maitin, 2002). In this context, resistant starch, pectin 
and other fiber components, as well as milk oligosaccharides are now suggested as having prebiotic 
potential (Coppa et al. 2006; Bird et al. 2010). 
   Synbiotics are defined as products containing both probiotics and prebiotics, and this combination 
is believed to be more efficient compared to probiotics and prebiotics alone in terms of gut health 
and function (Gibson and Roberfroid, 1995). The synbiotic formulation can be chosen following 
7 
 
two different criteria: (1) Complementary effect: single or multi strain probiotics, selected based on 
the specific desired host benefits, and prebiotics are independently chosen to stimulate beneficial 
gut microbial populations. Thus, the prebiotics increase the levels of resident gastrointestinal 
beneficial microbiota of the host (2) Synergistic effect: specific host beneficial probiotics are 
selected, and the prebiotic component is chosen to specifically enhance the survival, growth and 
activity of the selected ingested probiotic strain(s). However, an ideal synbiotic supplement should 
include both complementary and synergistic effects, containing an appropriate single or multi strain 
probiotic/s and suitable mixture of prebiotics, where the latter both selectively favors the former and 
also favors the multiplication of endogenous beneficial bacteria and the reduction of detrimental 
bacteria (Kolida and Gibson, 2011). 
 
3. Immunomodulating effects of pre- and probiotics: in vitro and ex vivo studies 
   The probiotic strains used for in vitro immunomodulation studies and their origin (where the 
information is available), as well as main results obtained, are listed in Table 1. The origins are very 
diverse, most are from human and pig intestine or faeces, but also strains isolated from human and 
animal milk have been studied in relation to their immunomodulating properties in vitro. 
 Pig intestinal cell lines for in vitro studies 
   Other than their barrier function, intestinal epithelial cells play an important role in the initiation 
of the mucosal immune response, as they represent the first line of defense against pathogens and 
toxic agents eventually reaching the intestinal lumen. Similarly to many immune cells involved in 
innate immunity, such as macrophages and dendritic cells, intestinal cells express on their surface 
the toll-like receptors (TLRs) that recognize structural components, widely conserved among 
different microorganism classes (Akira et al., 2006). Epithelial TLR expression is thought to play a 
key role in the host defense against pathogens by triggering innate immune responses, through 
activation of NF-kB and mitogen-activated protein kinase (MAPK) pathways, that ultimately lead 
to the production of pro-inflammatory cytokines and chemokines (Stadnyk, 2002; Oswald, 2006). 
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The use of in vitro cell lines allows characterization of host/microbe interactions at a basic level, 
representing a good starting point for further higher-level in vivo studies. In particular, four pig 
intestinal cell lines have been employed to investigate epithelial innate immune responses to many 
different microorganisms: a) intestinal porcine epithelial cells (IPEC)-1 (Gonzalez-Vallina et al. 
1996); b) intestinal porcine epithelial cells-jejunum (IPEC)-J2 (Schierack et al. 2006); c) ileal 
porcine intestinal (IPI)-2I cells (Kaeffer et al. 1993); d) porcine intestinal epitheliocyte (PIE) cells 
(Moue et al. 2008). 
   These studies aimed to evaluate the probiotic potential against several pathogen-induced damages, 
including adhesion to the epithelial cell membrane, alterations of tight junction integrity and 
induction of inflammatory response. 
 Probiotics used in pig intestinal cells challenged with ETEC 
   ETEC is a major pathogen of neonatal swine. It attaches to mucosal surfaces to release toxins that 
induce intestinal inflammation and diarrhea, resulting in reduced growth rate, increased mortality 
and economic loss (Fairbrother et al. 2005). The majority of the in vitro studies presented in this 
review have been conducted using this pathogen as challenge. 
   Enterococcus faecium NCIMB 10415, a probiotic that can reduce diarrhea incidence in piglets 
(Büsing and Zeyner, 2015; Zeyner and Boldt, 2006), has been investigated in ETEC-infected IPEC-
J2 cells, to deepen insight on the mechanisms underlying the bacterial-epithelial crosstalk during 
innate immune responses triggered by enteric infections. ETEC decreased transepithelial resistance 
(TEER) and increased IL-8 expression, and this effect could be prevented by both pre-incubation 
and simultaneous addition with E. faecium for up to 4 h (Klingspor et al. 2015; Lodemann et al. 
2015). Similarly, another E. faecium strain (HDRsEf1), as well as its cell-free supernatant, could 
attenuate ETEC K88-induced IL-8 secretion and TEER decrease in IPEC-J2 cells (Tian et al. 2016). 
It is interesting to note that a recent study using jejunal tissue explants in Ussing chambers revealed 
that increased expression of pro-inflammatory cytokines was accompanied with an initial TEER 
increase and reduced permeability towards macromolecules upon ETEC challenge when pigs were 
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fed control but not E. faecium strain NCIMB 10415 supplemented diets (Lodemann et al. 2017). In 
this study, changes in tight junction protein expression (i.e. down-regulation of claudin-4 with 
control but not E. faecium diet) were observed at later stages after the ex vivo ETEC infection 
showing the close link between early immune response and protection against a loss of barrier 
function with this probiotic strain. 
Several studies have also been conducted with strains belonging to the Lactobacillus genus. 
Downregulation of ETEC-induced increases in TLR4 and NOD2, receptors involved in pro-
inflammatory NF-κB signaling, as well as in TNF-α concentration, was observed with L. rhamnosus 
ATCC 7469. Moreover, this probiotic strain was able to enhance the intestinal barrier function by 
increasing ZO-1 and occludin protein expression, confirming that the protection from ETEC-
induced damage was achieved partly through the anti-inflammatory response and partly through the 
enhancement of tight junction integrity (Zhang et al. 2015). This same strain has been also used in 
in vivo trials, where it was found to positively modulate intestinal lymphocyte subpopulations in 
pigs challenged with ETEC (Zhu et al. 2014). Downregulation of the TLR4-dependent NF-κB and 
MAPK activation upon ETEC or lipopolysaccharide (LPS) challenge, with consequent reduction of 
IL-6 and IL-8 expression, was also observed with the the probiotic strain L. jensenii TL2937 in PIE 
cells (Shimazu et al. 2012). A new mechanism of counteracting the pathogenic effects of ETEC was 
demonstrated for two novel porcine isolates, L. johnsonii P47-HY and L. reuteri P43-HUV, that 
were able to induce the expression of cytoprotective heat shock protein (HSP)-27 and HSP-72, and 
to preserve barrier function and tight junction integrity in IPEC-J2 cells (Liu et al. 2015). Another 
interesting study evaluated the immunomodulatory effect of L. delbrueckii subsp. TUA4408L and 
its extracellular polysaccharide (EPS): acidic EPS (APS) and neutral EPS (NPS) against ETEC 
challenge in PIE cells. ETEC-induced inflammatory cytokines were downregulated when the cells 
were pre-stimulated with both L. delbrueckii or its EPSs. The anti-inflammatory capability of L. 
delbrueckii was diminished when PIE cells were blocked with anti-TLR2 antibody, while APS 
failed to suppress inflammatory cytokines when the cells were treated with anti-TLR4 antibody, 
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indicating that TLR2 played a principal role in the immunomodulatory action of L. delbrueckii, 
while the activity of APS was mediated by TLR4 (Wachi et al. 2014). Indeed, several studies have 
demonstrated that TLR2 is required by some probiotic strains to exert their immunomodulatory 
effects (Rizzo et al. 2013; Finamore et al. 2014).L. amylovorus strain DSM 16698, initially named 
L. sobrius (Konstantinov et al. 2006), has been used in both in vivo (see Section 5) and in vitro 
studies. This strain was able to prevent the cellular damage induced by ETEC K88 strain in IPEC-1 
cells, by strongly reducing ETEC adhesion, inhibiting the alterations of the tight junctions proteins 
ZO-1 and occludin, and counteracting the F-actin rearrangements and the alterations of IL-1ß, IL-8, 
and IL-10 gene expression induced by ETEC (Roselli et al. 2007). Anti-inflammatory activity of 
four different human-derived L. reuteri strains, namely DSM 17938, ATCC PTA4659, ATCC PTA 
5289, and ATCC PTA 6475, was evaluated in IPEC-J2 cells challenged with LPS. The four strains 
differentially affected LPS-induced IL-8 response in IPEC-J2 cells, as the three ATCC strains 
significantly inhibited IL-8 production, whereas DSM 17938 did not show this ability, highlighting 
the importance of considering the strain specificity, as responsible of the protective effects (Liu et 
al. 2010a). Another L. reuteri strain, I5007, was assayed for its protective activity against LPS, and 
it was observed that the expression of LPS-induced pro-inflammatory cytokines (TNF-α and IL-6), 
and TJ proteins (claudin-1, occludin and ZO-1) was reversed by pre-treatment with L. reuteri I5007 
or its culture supernatant (Yang et al. 2015a). Similar results were also obtained with some 
Lactobacillus reuteri isolates, LR1 and CL9, that were able from one side to inhibit the ETEC-
induced expression of pro-inflammatory cytokines IL-6, IL-8 and tumor necrosis factor (TNF)-α, as 
well as to increase the level of anti-inflammatory cytokine IL-10, and from the other side to 
maintain cell membrane barrier integrity, by preventing tight junction protein zonula occludens 
(ZO)-1 disruption (Wang et al. 2016; Zhou et al. 2014). 
   The anti-inflammatory and immunomodulatory effects of different bifidobacterial strains, 
Bifidobacterium breve MCC-117, B. longum BB536 and B. breve M-16V, were studied in PIE cells 
challenged with heat-killed ETEC. These strains were shown to activate TLR2 and upregulate some 
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TLR4 negative regulators, as ubiquitin-editing enzyme A20, thus reducing the activation of MAPK 
and NF-κB pathways and the subsequent production of pro-inflammatory cytokines (Murata et al. 
2014; Tomosada et al. 2013). Another study by the same authors using PIE cells and swine Peyer's 
patches immunocompetent cell co-culture system showed that the immunoregulatory effect of B. 
breve MCC-117 was related to its capacity to influence intestinal-immune cell interactions, leading 
to the stimulation of the regulatory T (Treg) CD4+CD25+Foxp3+ cell population among Peyer's 
patches immune cells, expressing high IL-10 levels (Fujie et al. 2011). 
The probiotic activity of a yeast strain, Saccharomyces cerevisiae CNCM I-3856, against ETEC 
challenge was explored in IPEC-1 and IPI-2I cells. The CNCM I-3856 strain was able to inhibit the 
ETEC-induced expression of pro-inflammatory cytokines and chemokines, and such inhibition was 
associated to a decrease of ERK1/2 and p38 MAPK phosphorylation (Zanello et al. 2011a). 
Moreover, this inhibition was dependent on secreted soluble factors, as the heat-killed yeast did not 
maintain the protective activity that indeed was maintained by yeast culture supernatant (Zanello et 
al. 2011b). 
 Probiotics used in pig intestinal cells challenged with enteropathogenic E. coli (EPEC) 
and Salmonella enterica 
   EPEC infection leads to serious acute diarrhea in weaned pigs, accompanied by high mortality 
rates (Zhu et al. 1994). Infection of intestinal epithelial cells by EPEC is a complex process, where 
initially EPEC loosely adheres to the epithelial cell membrane and translocates effector molecules 
into host cells. Subsequently the bacterium binds more tightly, intimately adheres to epithelial cells 
and forms microcolonies, resulting in histopathological alterations of the host cell surface, known as 
attaching and effacing (AE) lesions, that finally lead to microvilli destruction and loss of barrier 
function (Cleary et al. 2004). The E. coli Nissle 1917, a non-pathogenic E. coli strain with 
beneficial activity, has been employed as probiotic strain in pigs, where it has been shown to 
prevent the deleterious effects of pathogen-induced secretory diarrhea (Schroeder et al. 2006). 
Moreover, this strain could drastically reduce EPEC infection efficiency in vitro, by inhibiting 
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initial bacterial adhesion, due to strong adhesion capacity and secretion of inhibitory components, 
able to significantly reduce EPEC virulence-associated proteins (Kleta et al. 2014). 
   Another pathogen primarily associated with systemic invasive infection in swine is Salmonella 
enterica serovar Typhimurium, causing considerable economic losses and public health problems 
(Berends et al. 1996). Similarly to EPEC, Salmonella invades epithelial cells by using a specialized 
mechanism to inject its effector proteins into the cytoplasm through the host membrane surface. The 
action of injected proteins leads to a dramatic reorganization of the host actin cytoskeleton and to a 
vigorous epithelial cell membrane protrusion, and as a result the bacterium is engulfed inside the 
host cell (Ly and Casanova, 2007). E. coli Nissle 1917 showed similar inhibitory effects against 
Salmonella as those described for EPEC, and this inhibitory activity always correlated with 
probiotic adhesion capacity (Schierack et al. 2011). The Salmonella-induced inflammatory 
challenge was also used to evaluate the immunomodulatory activity of the two probiotic strains L. 
reuteri ATCC 53608 and Bacillus licheniformis ATCC 10716, that were able to  significantly 
inhibit Salmonella-stimulated IL-8 basolateral secretion (Skjolaas et al. 2007). 
Inhibition of adherence of several pathogens, belonging to the genera Salmonella, 
Clostridium, and Escherichia, has also been studied in a pig intestinal mucosa model, where two 
probiotic strains, B. lactis Bb12 and L. rhamnosus GG (LGG), alone and in combination, 
significantly reduced the adhesion of the tested pathogens (Collado et al. 2007). 
 Probiotics used in pig intestinal cells challenged with viruses 
    Some probiotics have also been explored for their potential antiviral activities. The first study 
showing that some probiotics could exhibit an antiviral activity has been conducted in IPEC-J2 cells 
infected with vesicular stomatitis virus (VSV), used as a model virus, as VSV is not a classical 
intestinal pathogen. Pre-incubation of cell monolayers with two Bifidobacterium (B. breve 
DSM20091 and B. longum Q46) and five Lactobacillus strains (L. paracasei A14, L. paracasei 
paracasei F19, L. paracasei/rhamnosus Q 85, L. plantarum M1.1 and L. reuteri DSM 12246) 
showed that these probiotics reduced viral infectivity through secretion of antiviral substances, and 
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prevented VSV binding to cell monolayers by interfering with virus attachment or entry into the 
cells, or by trapping the VSV itself (Botic et al. 2007). 
    Rotaviruses (RV), members of the Reoviridae family, are important etiologic agents of viral 
gastroenteritis in suckling and weaned piglets (Chang et al. 2012). Intestinal cells respond to RV 
infection by activating TLR3, that recognizes viral double stranded RNAThe TLR3-triggered innate 
immune response induced by RV was evaluated in PIE cells to select probiotic strains with specific 
anti-viral and immune enhancing properties. The strains L. casei MEP 221106 (Hosoya et al. 2011), 
L. casei MEP 221114 (Hosoya et al. 2013), L. rhamnosus CRL1505 (Villena et al. 2014), B. 
infantis MCC12 and B. breve MCC1274 (Ishizuka et al. 2016) were able to significantly reduce RV 
titers in infected cells and modulate several molecular markers of TLR3-triggered pathway, finally 
leading to NF-B activation and proinflammatory cytokine secretion. Liu and coauthors (2010b) 
used IPEC-J2 cells to compare the probiotic activity of L. acidophilus NCFM (LA) to the well 
known probiotic LGG. Although these two strains were not able to reduce virus replication into 
IPEC-J2 cells, they could differently modulate cellular immune response. Indeed, LA treatment 
prior to RV infection significantly increased virus-induced IL-6 response, consistent with the 
adjuvant effect of this strain, in potentiating immunogenicity of an oral RV vaccine in a gnotobiotic 
pig model (Zhang et al. 2008). On the contrary, LGG treatment post-RV infection downregulated 
the IL-6 response, confirming the well documented anti-inflammatory effect of LGG. 
    In conclusion, all the studies presented in this section have described how the various probiotic 
strains can exert immunomodulatory activities and contribute to the maintenance of intestinal 
homeostasis. These in vitro studies are quite consistent and clearly demonstrate that most of the 
different tested strains are able to counteract the pathogen-induced damages at various levels by 
virtue of several mechanisms of action, including reduction of pathogen adhesion, downregulation 
of inflammatory signaling pathways, reduction of pro-inflammatory cytokine secretion, 
maintenance of tight junction integrity. In some cases it has been demonstrated that the beneficial 
effects are maintained also by the spent culture supernatant, suggesting that one or more soluble 
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factors released by probiotic bacteria were responsible for the protective activity. However, it is 
important to consider that the beneficial effects are highly strain-specific, as clearly demonstrated in 
some studies observing different results on pathogen protection, by testing different strains from the 
same bacterial species. 
 In vitro studies with prebiotics 
Much less in vitro studies with prebiotics have been performed to test for direct (microbiota-
independent) immunomodulatory effects. In one study the prebiotic β-galactomannan was used to 
evaluate the protective role against S. enterica serovar Typhimurium infection in IPI-2I cells, and 
interestingly this prebiotic was found to attenuate Salmonella-induced secretion of pro-
inflammatory cytokine IL-6 and chemokine CXCL8 (IL-8). The authors concluded that the 
particular oligosaccharide structure of β-galactomannan was able to interfere with pathogen 
adhesion (Badia et al. 2013). In a previous study by the same authors, β-galactomannan was used 
and compared to Saccharomyces cerevisiae var. boulardii. Both prebiotic and probiotic were able to 
inhibit the in vitro ETEC adhesion to IPI-2I cells, and to decrease the ETEC-induced gene 
expression of pro-inflammatory cytokines TNF-α, IL-6, granulocyte-macrophage colony-
stimulating factor (GM-CSF) and chemokines CCL2, CCL20 and CXCL8. Very similar results 
were obtained by using the S. enterica serovar Typhimurium challenge model (Badia et al. 2012a 
and 2012b). 
 
4. Influence of supplemental pre- and probiotics on the intestinal microbiota 
   The intestinal microbiota composition in pigs is very dynamic and is subject to change over time, 
especially in early life. As the microbiota composition has a large impact on many aspects of the 
host’s health (i.e., digestion of feed to breakdown products, stimulation of the immune system, 
competition with pathogens), it plays an important role in maintenance of health. To date, several 
studies have focused on the possibility of changing the microbiota composition in pigs by particular 
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feed supplementation with either pre- or probiotics (see Tables 2 and 3 for representative 
examples). 
   Frequently investigated prebiotics in pig microbiota composition studies are fermentable 
carbohydrates, which are linked to improvement of the microbial balance in both the small and 
large intestines by stimulating the carbohydrate metabolism. Pig microbiota composition and 
functionality can also be affected by other natural feed additives, such as milk components, proteins 
and fats (Bauer et al. 2006). Positive effects regularly ascribed to prebiotics are a bifidogenic effect 
(meaning the stimulation of bifidobacteria) or a butyrogenic effect (meaning the stimulation of 
butyrate producing bacteria). Also, the reduction of enteropathogens growth is often considered 
when studying the effect of a particular prebiotic as will be addressed below. 
    It has been observed that a diet high in resistant starch can change the microbiota composition in 
both the caecum and colon of adult pigs: in the colon, the healthy gut-associated butyrate-producing 
Faecalibacterium prausnitzii was stimulated, whereas potentially pathogenic members of the 
Gammaproteobacteria, including E. coli and Pseudomonas spp. were reduced in relative abundance 
(Haenen et al. 2013). Furthermore, Loh et al. (2006) showed that the addition of inulin to the diet 
led to an increase in the abundance of colonic bifidobacteria. In addition, total colonic short-chain 
fatty acid (SCFA) concentrations were lowered due to reduced acetate, although the proportion of 
colonic butyrate was higher in pigs fed inulin-supplemented diets. In another study, the amounts of 
both lactobacilli and bifidobacteria were increased in the caecum upon addition of inulin to the diet 
(4%) (Tako et al. 2008). 
   In two studies carried out by Pierce et al. (2006; 2007), it was shown that the addition of lactose 
increased the amounts of lactobacilli and bifidobacteria in the caecum and colon of weaning piglets, 
while E. coli numbers were decreased. The inclusion of lactose to the diet also resulted in increased 
SCFA concentrations in the colon (Pierce et al. 2006; Pierce et al. 2007). Other milk components, 
i.e, milk oligosaccharides have also been studied. These are major components of mammalian milk, 
whereas little is known on the oligosaccharide profile of porcine milk, although it has recently been 
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shown that porcine milk contains 29 distinct oligosaccharides (Tao et al. 2010). Several animal 
studies showed that both FOS and GOS were linked to a bifidogenic effect. For instance, piglets fed 
a diet supplemented with FOS post-weaning had increased bifidobacteria and reduced E. coli in the 
proximal colon (Gebbink et al. 1999). Similarly in another study, it was shown that piglets fed a 
diet supplemented with GOS post-weaning had increased numbers of bifidobacteria in the proximal 
and transverse colon (Tzortzis et al. 2005). 
   Beta-glucans have gained special focus due to their immune-stimulatory properties, since they 
interact with specific receptors of the innate immune system such as dectin-1 on dendritic cells 
(Vannucci et al. 2013). Next to the immune-stimulatory properties, beta-glucans can modulate the 
gut microbiota. Oat-derived beta-glucans have been shown to raise the numbers of lactobacilli and 
bifidobacteria in the colon (Metzler-Zebeli et al. 2011), while yeast-derived beta-glucans reduced 
Enterobacteriaceae counts in the colon (Sweeney et al. 2012) (Table 2). 
    Addition of arabinoxylans to the feed resulted in a higher number of Faecalibacterium 
prausnitzii, Roseburia intestinalis, Blautia coccoides-Eubacterium rectale, Bifidobacterium spp. 
and Lactobacillus spp. in the faeces. In conclusion, addition of arabinoxylans to the feed shifted the 
microbial composition towards butyrate-producing species, and, as an additional effect, the butyrate 
concentration in the large intestine was increased (Nielsen et al. 2014). 
    The general mode of action by which many probiotics influence the intestinal microbiota is their 
ability to competitively exclude the growth of pathogens. Table 3 provides representative examples 
of studies addressing the influence of probiotics on porcine microbiota composition. Production of 
lactic acid by lactobacilli is responsible for the lowering of pH, which is related to the reduction of 
growth rates of potential pathogens like Salmonella and E. coli. Furthermore, many lactobacilli are 
capable to produce peptide-based molecules known as ‘bacteriocins’ which can inhibit the growth 
of similar or closely related bacteria (Cotter et al. 2005). Using cultivation-dependent methods, 
studies using oral treatments of piglets with probiotics have shown a positive influence on the 
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microbiota in terms of decreased numbers of potential pathobionts and increased numbers of 
beneficial bacteria (Table 3). 
 
5. In vivo studies with probiotics and intestinal disorders 
   The main interests in feeding probiotics, and synbiotics are the health benefit especially in terms 
of diarrhea reduction and performance improvement in piglets (e.g. Hodgson and Barton, 2009). 
 Prevention of diarrhea 
Some of the studies addressing the influence of probiotics on microbiota composition have also 
included performance and diarrhea (Table 4): in the study by Huang et al. (2004), the Lactobacillus 
preparation significantly decreased E. coli counts and anaerobe counts while also significantly 
decreasing diarrhea incidence. When B. longum was added to the diet as a supplement, reduced 
numbers of total anaerobes and clostridia in the faeces were observed, indicating that the 
administration of bifidobacteria could provide a beneficial effect on pig growth and performance 
(Estrada et al. 2001). Supplementation of the probiotic L. amylovorus DSM 16698 couldreduce the 
levels of ETEC expressing K88/F4 fimbriae, in the ileum of challenged piglets. In addition, an 
improved daily weight gain was observed when compared to the control group (Konstantinov et al. 
2008). In another study it was found that pretreatment with E. coli Nissle 1917 completely 
abolished clinical signs of secretory diarrhea in a model of intestinal infection with an ETECstrain 
(Schroeder et al. 2006). . Pigs fed a diet supplemented with the probiotic E. faecium strain CECT 
4515 showed increased counts of lactobacilli in ileum, caecum and faeces and a reduced number of 
coliforms in the ileum. In addition, the probiotic resulted in heavier piglets, caused by a 
significantly improved growth and feed conversion ratio (Mallo et al. 2010). Similarly, when 
Bacillus subtilis LS 1-2 fermented biomass was added to the diet, counts of Clostridium spp. and 
coliforms were reduced in the caecum. Additionally, B. subtilis fermented biomass resulted in 
enhanced growth rate and enhanced feed conversion ratio (Lee et al. 2014). Hence, several studies 
amongst others shown in Table 4 have concluded that probiotics supplementation exert a beneficial 
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effect on diarrhea reduction and growth, however, it should be noted that the studies may not have 
been experimentally designed to study these parameters. Moreover,, contrasting results can be 
obtained in the literature. Reasons for this are not clear but could be related to experimental settings, 
diets, initial microbiota colonization, administration route, time and frequency of probiotic strain 
administration, differences in strains from the same microbial species, and sampling for analysis. 
For example, some studies using E. faecium NCIMB 10415 showed that diarrhea was reduced and 
performance increased (Taras et al. 2006; Zeyner and Boldt, 2006; Büsing and Zeyner, 2015) 
whereas others did not (Broom et al. 2006; Martin et al. 2012). It was initially shown that E. 
faecium NCIMB 10415 could be transferred already from the mother to the piglets during the early 
postnatal period (Macha et al. 2004; Taras et al. 2007; Starke et al. 2013). Depending on the 
administration route (daily oral dose or within the feed of sows and piglets), different amounts of 
the probiotic strain could be recovered (Taras et al. 2007). In these studies, it was shown that in 
suckling piglets receiving no supplemented feed, E. faecium reached similar fecal cell counts as 
compared to weaned piglets receiving probiotic supplemented feed, suggesting that this strain is 
capable to occupy a niche within the intestinal ecosystem. Feeding E. faecium to piglets 1-14 days 
of age decreased the number of E. coli in faeces, decreased pH in the duodenum and increased the 
concentration of lactic and propionic acid in the colon (Strompfova et al. 2006). Interestingly, 
feeding the strain to sows and their piglets showed effects on intestinal microbial community 
composition but also showed some animal-specific variability with so-called “responders” and 
“non-responders” (Starke et al. 2013). This phenomenon has not been further clarified yet but 
should probably be addressed with regard to experimental designs and data interpretation. In vitro 
co-culture experiments and in vivo analyses showed that this probiotic strain could reduce the 
growth of other enterococci and pathogenic E. coli (Vahjen et al. 2007; Starke et al. 2015). 
Similarly, data from in vivo feeding trials showed that E. faecium NCIMB 10415 did not affect the 
diversity and number of luminal enterobacteria but reduced the abundance of E. coli virulence 
factors and the number of pathogenic E. coli adhering to the intestinal mucosa (Taras et al. 2006; 
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Scharek et al. 2005; Bednorz et al. 2013). In contrast, two independent but similar challenge 
experiments with S. Typhimurium showed no protective effect of the probiotic E. faecium NCIMB 
10415 on pathogen shedding in weaned pigs (Szabo et al. 2009; Kreuzer et al. 2012). An 
explanation could be that Salmonella has evolved manifold strategies to evade or down-regulate the 
host immune system and spread beyond intestinal boundaries (Monack, 2013). In this context, it 
could be possible that – despite the protective effect against pathogenic E. coli - some 
immunomodulating properties of E. faecium NCIMB 10415 in pigs could cause a disadvantage for 
the host upon challenge with Salmonella. For example, it was initially shown that feeding E. 
faecium NCIMB 10415 reduced the number of intraepithelial cytotoxic T-cells and fecal IgA in 
weaned piglets (Scharek et al. 2005; Scharek et al. 2007). Further analyses confirmed that E. 
faecium likely exerts anti-inflammatory/immuno-suppressive reactions in suckling piglets, which 
are then intensified during the weaning time (e.g. reduced expression levels of IL-8, IL-10 and no 
change in T-cell inhibitory molecule CTLA4 in jejunal and ileal Peyer’s patches) and thereby opens 
a so called “window of opportunity” for Salmonella to colonize and persist in the host (Twardziok 
et al. 2014; Siepert et al. 2014). A recent study further suggests that this early-life effect on the 
immune response may be promoted not only through the transfer of the probiotic itself but also 
through immunoactive compounds (i.e. CD14 expressing epithelial cells) from the probiotic-fed 
mother via the milk (Scharek-Tedin et al. 2015). 
   Another probiotic, Bacillus toyonensis sp. nov. (previously known as B. cereus var. toyoi, 
Jimenez et al. 2013) has been used for many years in pigs and has been shown to reduce the 
incidence of diarrhea and improve feed efficiency (Taras et al. 2005). B. toyonensis has been 
associated with a decreased ETEC number and morbidity in weaned piglets (Papatsiros et al. 2011, 
Table 4). Feeding of B. toyonensis to sows changed their intestinal microbiota, and this probiotic 
was shown being transferred to the neonatal piglets and significantly alter the intestinal 
fermentation patterns during the early suckling period and weaning (Kirchgessner et al. 1993; 
Jadamus et al. 2002). One of the main modes of action of Bacillus spp. in pigs might be through 
20 
 
their immunomodulating properties. Probiotic treatment with spore formers such as B. toyonensis 
have been shown to lead to an increased abundance of intraepithelial cytotoxic T-cells and fecal 
IgA in weaning pigs, which may confer protection against pathogen colonization (Scharek et al. 
2007; Schierack et al. 2009). In fact, a challenge trial with S. Typhimurium showed that piglets in 
the control group responded to S. Typhimurium challenge with reduced growth and high incidence 
of diarrhea, which was less pronounced in piglets fed with the probiotic (Scharek-Tedin et al. 
2013). 
    Several different Lactobacillus spp. and strains have been used in past studies in pigs showing 
effects on the intestinal microbial communities or beneficial activities under ETEC, Salmonella or 
RV challenge conditions. These studies included L. plantarum, L. amylovorus DSM 16698, L. 
reuteri or LGG. L. amylovorus DSM 16698 was also used in an experiment performed on pig 
intestinal explants, where ETEC induced a higher level of TLR4, P-IKK, P-IκB, and P-p65, 
while L. amylovorus completely abolished all these alterations and upregulated the negative TLR4 
regulators Tollip and IRAK-M expression, when co-treated with ETEC (Finamore et al., 2014). In 
particular, L. amylovorus was effective in reducing ETEC K88 colonization (Table 3) and could 
improve the weight gain of infected piglets (Konstantinov et al. 2008), while the administration of 
L. plantarum DSM 8862 and 8866 strains at weaning could influence gastrointestinal microbiota in 
piglets, with positive outcomes on gastrointestinal health (Pieper et al. 2009). Several L. reuteri 
strains have been used in pig trials, in particular, the I5007 strain has been shown to have beneficial 
effects on performance and growth, prevention of diarrhea, altered gut microbiota, and 
immunomodulation (reviewed by Hou et al. 2015). Finally, LGG supplementation could alleviate 
the diarrhea in RV-challenged weaned piglets through inhibition of virus multiplication, as well as 
improvement of intestinal mucosal barrier function and of intestinal microbiota composition (Mao 
et al. 2016). 
   Studies performed with synbiotics in relation to E. coli related diarrhea are limited (Table 5), and 
to date, different synbiotic combinations have been used in weaning piglets after E. coli challenge 
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with variable results. The study by Krause et al. (2010) concluded that the use of E. coli probiotic 
strains UM-2 and UM-7 against ETEC K88 in the presence of raw potato starch positively impacted 
on piglet growth performance and resulted in a reduction of diarrhea and increased microbial 
diversity in the gut. In another study, the synbiotic combination of lactulose and L. plantarum JC1 
strain showed a good potential to be used to control post-weaning colibacillosis in piglets (Guerra-
Ordaz et al. 2014). 
 
6. The link between the intestinal microbiota and the mucosal immune system  
It has been demonstrated that axenic or germ-free animals mature physically without the 
contribution of microbial colonization but remain functionally immature in many systems including 
mucosal and systemic immunity, development of secondary lymphoid tissues, and 
susceptibility/response to pathogens (reviewed by Smith et al. 2007). These results provide a strong 
initial basis to demonstrate that the maturation of the immune system depends on both colonization 
and diversification of the intestinal tract with symbiotic microorganisms. Thus, understanding the 
role of the host-microbiota interplay for shaping local and systemic immunity is a key issue for 
identifying efficient strategies to modulate the gut microbiota with the goal of promoting host health 
and resilience in the face of pathogens. Note also that, despite a known and well-acknowledged 
strong impact of maternal colonization and environmental parameters for driving the gut microbiota 
composition, the genetics of the host is also likely to play a role (Goodrich et al. 2014; Dabrowska 
and Witkiewicz, 2016), and questions on how to measure heritability of the microbiomes have been 
raised (van Opstal et al. 2015). Clearly, distinguishing true genetic predisposition from vertical 
transmission from the sow to her piglets is important when assessing ‘heritability’ of microbiomes. 
In addition, estimating ‘heritability’ of microbiomes from simple breed or strain differences may 
also be flawed. Thus, initial studies in rodents suggested that knocking out TLRs and their signaling 
pathways resulted in changes in the microbiomes: however, recent studies demonstrate that this 
effect is likely to be a consequence of maintaining separate wild-type and knockout colonies (Ubeda 
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et al. 2012). Despite these difficulties, several recent studies in mice have shown that genetic loci 
influence the relative abundances of specific microbial taxa in the gut (Benson et. al., 2010), and 
that polymorphisms in the major histocompatibility complex contribute to shape individual’s unique 
microbial patterns that influence the susceptibility to enteric pathogens and thus health (Kubinak et 
al. 2015). Variants of the FUT1 genotype, which has recently been highlighted for its property on 
controlling expression of the receptor for ETEC F18; may also affect the commensal intestinal 
microbiota and host metabolism and immune response of non-infected pigs (Poulsen, 2016). 
      Because of the high level of variability in growth and feed conversion between individual pigs 
in commercial husbandry systems, measuring the impact of prebiotics, probiotics or synbiotics on 
gut health defined by improvements in overall productivity requires large experiments. For this 
reason and as described in the previous sections, many studies have concentrated on measuring the 
effects of diet or bacteria on proxies of gut health including many immunological measures and 
changes in the microbiota, in more controlled experiments and physical environments. In model 
species such as laboratory rodents, colonization with single microorganisms or administration of 
their products can have profound effects on immunological responses in the intestinal mucosa, and 
microbiota species have been described with immunomodulatory effects in the GIT. For example, 
the presence or absence of a single bacterial species, the segmented filamentous bacterium, can 
result in marked differences in mucosal T-cell numbers and functions, including Th17 and Treg 
cells (Ivanov et al. 2008; Gaboriau-Routhiau et al. 2009), Similarly, Bacteroides fragilis was shown 
to direct the development of Foxp3+ Tregs in the colon (Liu et al. 2008; Mazmanian et al. 2005; 
Mazmanian et al. 2008; Round et al. 2011); members of Clostridium cluster IV (C. leptum group) 
and XIVa (C. coccoides group) were reported to promote the expansion of colonic and systemic 
Tregs (Wingender et al. 2012); Sphingomonas yanoikuyae was shown to modulate the phenotype 
and response of invariant NKT cells (Atarashi et al. 2011; Atarashi et al. 2013). Hence, the link 
between microbiome and mucosal immune system is clear. Similarly, colonization of germ-free 
mice with microbiota derived from mice or humans with different obesity phenotypes (lean or 
23 
 
obese) can result in recapitulation of the phenotype of the donor, establishing a causal link between 
the microbiome and metabolism (Turnbaugh et al. 2006; Ridaura et al. 2013). 
    Similar administration of single or complex mixtures of probiotic organisms can also have 
marked effects on immunological measures in pigs. In the most reductionist version of the 
experiment, colonization of true germ-free pigs recapitulates postnatal development of the mucosal 
immune system (Laycock et al. 2012). In 70-day-old Large White pigs with more complex, 
naturally establishing microbiomes, the presence of ‘enterotypes’ characterised by Ruminococcus or 
Prevotella was associated with differences in luminal secretory IgA concentrations, as well as body 
weight (Mach et al. 2015), higher IgA levels and growth performances being seen in pigs with the 
Prevotella-dominated microbiomes. In this report, there was no antagonism between IgA levels 
expected to be protective and production traits. The two ‘enterotypes’ were refined with more than 
500 60-day-old piglets, the Prevotella-enterotype being also dominated by Mitsuokella and the 
Ruminococcus-enterotype by Treponema (Ramayo-Caldas et al. 2016). 
    Nevertheless, direct intervention with single probiotics has produced conflicting results. In one 
study, administration of B. lactis NCC2818, an organism with established probiotic activity in 
humans and rodents, resulted in overall reduction in IgA secretion in the intestine, rather than an 
increase (Lewis et al. 2013). This was associated with an increased expression of the enterocyte 
tight-junction protein ZO-1, suggesting that increased barrier function might have resulted in 
decreased antigen uptake and reduced stimulation of IgA production. In contrast, other studies have 
shown an increase in IgA as a consequence of feeding the probiotics E. faecium NCIMB 10415, 
SF68 and Bacillus cereus var. toyoi NCIMB 40112, and suggested that the probiotic effect may be 
attributable to increased IgA providing better protection at mucosal surfaces (Scharek et al. 2007). 
 
  7. Conclusions and future perspectives 
    The literature review provided here has revealed that many porcine studies have been performed 
showing that probiotics can influence the gut microbiota, and are having immunomodulatory 
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effects. These effects have especially been studied with the goal to inhibit pathogens and enteric 
diseases. However, contrasting results can be observed in the literature. Reasons for this are not 
clear but could be related to experimental settings, diets, initial microbiota colonization, 
administration route, time and frequency of the probiotic strain, differences in strains from the same 
microbial species and sampling for analysis. In addition, our review reports studies showing the 
influence of prebiotics on the porcine microbiota composition, but only few studies in pigs are 
available yet on the combination of pre- and probiotics in relation to gut health parameters. The 
main interests in feeding probiotics or synbiotics are the reduction in diarrhea and improvement in 
performance in piglets. 
     However, in this context it should be stressed that the current use of proxy measurements of 
enteric health based on observable immunological parameters presents significant problems. The 
immune system functions to provide protection against true pathogens and against ubiquitous 
organisms with only mild negative effects on enteric health such as the ‘pathobionts’ identified in 
mouse intestinal microbiomes (Chow et al. 2011). However, expression of immunological functions 
in the intestinal mucosa can result in clearance or exclusion of such micro-organisms (a ‘good’ 
thing) while mediating inflammation (a ‘bad’ thing). As a result, the overall impact of any of the 
immunological parameters which we commonly measure on health and performance is, currently, 
difficult to predict. We strongly suggest that the value of such measures is as explanatory variables: 
that is, they should be used to understand a mechanism which has been defined either previously or 
in the same experiment by more robust, meaningful measures of enteric health. These proxy 
measures are necessary to understand and develop mechanistic models which, in future, will allow 
rational prediction of the effect of specific probiotic or synbiotic interventions: however, at the 
moment, they cannot be considered robust, reliable predictors of probiotic, or synbiotic activity and 
efficacy in relation for diarrhea reduction and improvement in performance. 
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Table 1. Probiotic strains used in pig intestinal cell lines and main results. 
Strains Origin and source Results Reference 
Lactobacillus amylovorus DSM 16698 
(previously called L. sobrius) 
Piglet intestine Protection against ETEC 
K88 adhesion and 
membrane damage 
Roselli et al., 2007 
Bifidobacterium breve DSM 20091 
B. longum Q 46 
L. paracasei A14 
L. paracasei F19 
L. paracasei/rhamnosus Q 85 
L. plantarum M1.1 
L. reuteri DSM 12246  
Infant intestine 
n.d. 
n.d. 
n.d. 
n.d. 
Human babies faeces 
Pig faeces 
Reduction of viral 
infectivity and adhesion, 
through secretion of 
antiviral substances 
Botić et al., 2007 
L. reuteri ATCC 53608 
Bacillus licheniformis ATCC 10716 
Swine intestine 
isolate 
n.d. 
Inhibition of Salmonella-
stimulated IL-8 
basolateral secretion 
Skjolaas et al., 2007 
L. reuteri DSM 17938 
L. reuteri ATCC PTA4659 
L. reuteri ATCC PTA 5289 
L. reuteri ATCC PTA 6475 
Human milk 
Human milk 
Human oral cavity 
Human milk 
Inhibition of LPS-induced 
IL-8 secretion by the the 
three ATCC strains 
Liu et al., 2010a 
L. acidophilus NCFM (LA) 
L. rhamnosus GG ATCC 53103 
Human adult faeces 
Human adult faeces 
LA pretreatment: increase 
of virus-induced Il-6 
response 
LGG post-treatment: 
downregulation of Il-6 
response 
Liu et al., 2010b 
L. casei MEP221106 n.d. Antiviral activity, 
modulation of TLR3- 
triggered pathway 
Hosoya et al., 2011 
Saccharomyces cerevisiae CNCM I-
3856 
S. cerevisiae var boulardii CNCM I-
3799 
n.d. 
n.d. 
Inhibition of ETEC-
induced pro-inflammatory 
cytokines, downregulation 
of MAPK pathway 
Zanello et al., 2011a and 
2001b 
Escherichia coli Nissle 1917 DSM 
6601 
Human Regulation of Salmonella 
virulence genes 
expression and adhesion 
Schierack et al., 2011; 
Kleta et al., 2014 
B. breve MCC-117 n.d. 
 
Stimulation of Treg cells 
from Peyer’s patches 
TLR2 activation and 
TLR4 negative regulators 
upregulation 
Fujie et al., 2011; 
Murata et al., 2014 
L. jensenii TL2937 Human faeces Downregulation of NF-kB 
pathway, activated by 
ETEC or LPS 
Shimazu et al., 2012 
L. casei MEP221114 Human faeces Antiviral activity, 
modulation of TLR3- 
triggered pathway 
Hosoya et al., 2013 
B. longum BB536 
B. breve M-16V 
n.d. 
 
TLR2 activation and 
TLR4 negative regulators 
upregulation 
Tomosada et al., 2013 
L. reuteri CL9 n.d. Inhibition of ETEC-
induced pro-inflammatory 
cytokine expression 
Zhou et al., 2014 
L. delbrueckii TUA4408L Sunki, japanese 
fermented pickle 
Downregulation of ETEC-
induced inflammatory 
cytokines, mediated by 
TLR2 
Wachi et al., 2014 
L. rhamnosus CRL1505 Goat milk Antiviral activity, 
modulation of TLR3- 
triggered pathway 
Villena et al., 2014 
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Enterococcus faecium NCIMB 10415 Infant faeces Inhibition of ETEC-
induced TEER decrease 
and IL-8 secretion 
Klingspor et al., 2015; 
Lodemann et al., 2015 
L. reuteri I5007 Piglet intestine Reduction of LPS-induced 
pro-inflammatory 
cytokines and TJ proteins 
Yang et al., 2015a 
L. rhamnosus ATCC 7469 n.d. Attenuation of ETEC-
induced NF-kB signaling; 
enhancement of barrier 
integrity 
Zhang et al., 2015 
L. rhamnosus GG ATCC 53103 
L. johnsonii P47-HY 
L. reuteri P43-HUV 
Human adult faeces 
Pig ileal digesta 
Pig ileal digesta 
Induction of 
cytoprotective HSP, 
preservation f barrier 
function 
Liu et al., 2015 
B. infantis MCC12 
B. breve MCC1274 
n.d. 
n.d. 
Antiviral activity, 
modulation of TLR3- 
triggered pathway 
Ishizuka et al., 2016 
L. reuteri LR1 Weaned piglet faeces Inhibition of ETEC 
adhesion and pro-
inflammatory cytokine 
expression, maintenance 
of membrane barrier 
integrity 
Wang et al., 2016 
E. faecium HDRsEf1 Pig faeces Inhibition of ETEC-
induced IL-8 secretion 
and TEER decrease 
Tian et al., 2016 
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Table 2. Influence of prebiotics on porcine microbiota composition 
Prebiotics  Dose Age and period of 
treatment 
Analyzing 
method 
Results Reference 
Resistant starch Diet high in 
resistant starch 
(34%) 
Adult female pigs 
received diet for 2 
weeks. 
16S rRNA V6-8 
PCR amplicons 
on DGGE and 
PITChip 
Stimulation of 
Faecalibacterium 
prausnitzii and reduction of 
E. coli and Pseudomonas 
spp. in the colon. 
(Haenen et al. 
2013) 
Inulin Diet supplemented 
with 3% inulin 
Pigs of 9-12 weeks of 
age received the diet 
for 3 or 6 weeks. 
FISH with 59-
Cy3 labeled 16S 
or 23S rRNA 
oligonucleotide 
probes  
Inulin supplementation 
increased the number of 
pigs harboring 
Bifidobacteria. 
(Loh et al. 
2006) 
Diet supplemented 
with 4% inulin 
Anaemic piglets of 5 
weeks of age received 
the diet for 6 weeks. 
Amplification of 
16S rDNA 
targeted probes 
Inulin supplementation 
increased Lactobacillus and 
Bifidobacterium 
populations in the caecum. 
(Tako et al. 
2008) 
Diet supplemented 
with 1.5% inulin 
Piglets weaned at 28 
days of age, fed the 
diet for 11 days, 
experiment performed 
at commercial and 
experimental farms 
16S rRNA V6-8 
PCR amplicons 
on DGGE, and  
cultivation-
dependent 
methods 
Inulin supplementation 
increased bacterial 
diversity, but did not affect 
metabolites, changes were 
more obvious under 
commercial farm conditions 
(Janczyk et al. 
2010) 
Lactose 125 and 215 g/kg Piglets of 33 days of 
age were assigned to 
12-day period of 
commercial creep feed, 
followed by 28 days of 
experimental diets. 
Cultivation-
dependent 
methods 
Pigs offered 215 g/kg 
lactose had a higher 
Bifidobacteria population in 
their faeces than pigs 
offered 125 g/kg. 
(Pierce et al. 
2007; Pierce et 
al. 2006) 
FOS Diet supplemented 
with 5% FOS 
Piglets were weaned at 
26 to 28 days of age, 
then fed the 
experimental diets for 
4 weeks. 
Cultivation-
dependent 
methods 
FOS increased 
Bifidobacteria and reduced 
E. coli in the proximal 
colon. 
(Gebbink et al. 
1999) 
GOS Diet supplemented 
with 4% GOS 
35 day old male pigs 
received the 
experimental diet for 
34 days. 
Bacterial 
enumeration by 
fluorescence in 
situ hybridization 
(FISH) 
GOS increased the number 
of Bifidobacteria in the 
proximal and transverse 
colon. 
(Tzortzis et al. 
2005) 
Oat-derived 
beta-glucans 
Diet supplemented 
with 8.95% of oat 
beta-glucan 
concentrate 
Piglets were weaned at 
21 days of age, then 
fed the experimental 
diets for 2 weeks. 
Quantitative PCR Oat beta-glucan raised 
Lactobacilli and 
Bifidobacteria numbers in 
the colon.  
(Metzler-Zebeli 
et al. 2011) 
Yeast-derived 
beta-glucans 
Diet supplemented 
with 250 ppm beta-
glucans 
49 day old pigs were 
fed the experimental 
diets for 28 days. 
Cultivation-
dependent 
methods 
Yeast beta-glucans reduced 
Enterobacteriaceae counts 
in the colon. 
(Sweeney et al. 
2012) 
Arabinoxylans Diet designed to 
hold 17% of 
Arabinoxylans 
Adult female pigs 
received diet for 3 
weeks. 
Quantitative PCR 
assays on 16S 
ribosomal DNA 
Higher number of 
Faecalibacterium 
prausnitzii, Roseburia 
intestinalis, Blautia 
coccoides- Eubacterium 
rectale, Bifidobacterium 
spp. and Lacobacillus spp. 
(Nielsen et al. 
2014) 
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Table 3. Influence of probiotics on porcine microbiota composition. 
Probiotics  Dose Age and period 
of treatment 
Analyzing 
method 
Results Reference 
Complex Lactobacilli 
preparation, which 
included Lactobacillus 
gasseri, L. reuteri, L. 
acidophilus and L. 
fermentum 
105 CFU/ml in 
drinking water 
Piglets were 
weaned at 28 
days. Treatment 
was first week 
after weaning. 
Cultivation-
dependent 
methods 
Decrease of E. 
coli and increase 
of Lactobacilli 
numbers in 
digesta and 
mucosa of most 
sections of the GI 
tract. 
(Huang et al. 
2004) 
Bifidobacterium 
longum strain 75119 
Twice an oral 
dose of 1010 
CFU 
Piglets were 
weaned at 18 
days. Treatment 
was on day 1 and 
day 3 after 
weaning. 
Cultivation-
dependent 
methods 
Reduced 
numbers of total 
anaerobes and 
Clostridia, and 
increased 
numbers of 
Bifidobacteria in 
faeces. 
(Estrada et al. 
2001) 
E. coli Nissle 1917 108 CFU 
single dose 
One week old 
gnotobiotic pigs 
were orally 
mono-associated. 
Cultivation-
dependent 
methods 
Reduced 
Salmonella 
Typhimurium 
translocation 
after challenge. 
(Splichalova et 
al. 2011) 
L. sobrius/amylovorus 
DSM 16698 
1010 CFU/day Administration 
throughout entire 
experiment. 
Cultivation-
dependent 
methods 
Reduced ETEC 
levels in the 
ileum after 
challenge. 
(Konstantinov et 
al. 2008) 
Enterococcus faecium 
strain CECT 4515 
106 CFU/g 
feed 
28 day old piglets 
were given the 
diet for 4 weeks. 
Cultivation-
dependent 
methods 
Increased counts 
of Lactobacilli in 
ileum, caecum 
and faeces and 
reduced numbers 
of coliforms at 
the ileum level. 
(Mallo et al. 
2010) 
Lactobacillus 
plantarum strains 
DSM 8862 and 8866 
Single dose 
with 5 x 109 or 
5 x 1010 CFU 
Single oral dose 
either before (25 
days of age) or at 
the time point of 
weaning (28 days 
of age) 
Cultivation-
independent 
methods 
Increased 
bacterial 
diversity and 
abundance of 
potentially 
health-promoting 
bacteria when 
probiotics where 
administered at 
28 days of age 
(Pieper et al. 
2009) 
Bacillus subtilis LS 1-
2 
4,5 g 
fermentation 
biomass/kg 
feed 
21 day old piglets 
were given the 
diet for 4 weeks 
Cultivation-
dependent 
methods 
Reduced 
Clostridium and 
coliforms counts 
in the caecum. 
(Lee et al. 2014) 
 
51 
 
Table 4. Influence of probiotics and prebiotics on pathogen adhesion and diarrhea in pigs 
 
Probiotics/prebiotics Dose Age and period 
of treatment 
Results Reference 
Bacillus cereus var. toyoi 
spores  
1.9x109 spores/g feed Pigs weaned at d 
28 of age, 5 
weeks  
Reduced diarrhea score 
and number of ETEC 
with probiotics 
Papatsiros et al. 
2011 
Bacillus pumilus WIT 
588 
5x1010 spores per pig 
and >1010 spores per 
pig (topdress) 
Pigs 1-21 days 
after weaning 
Reduction in numbers 
of E. coli in ileum 
Prieto et al. 2014 
Enterococcus faecium 
EK130 
2x109 CFU/piglet Piglets 1-14 days 
of age 
Reduced number of E. 
coli in faeces 
Strompfova et al. 
2006 
Lactobacillus 
acidophilus or 
Pediococcus acidilactici 
1.7 x 107 CFU/ml Weaned piglets 
18-21 days old, 5 
weeks 
Reduction in number 
of coliforms when fed 
L. acidophilus 
compared to P. 
acidilactici  
Wang et al. 2012 
Bacillus licheniformis 
DSM5749. Bacillus 
subtilis DSM5750 
3.9x108 CFU/day (low 
dose) 
7.8x108 CFU/day 
(high dose) 
Weaned piglets 
21-36 days of age 
Ameliorated 
pathophysiological 
changes cause by E. 
coli F4 infection.  
Zhou et al. 2015 
Lactobacillus plantarum 
strains DSM 8862 and 
8866 
Single dose of 3x109 
or 3x1010 CFU at 28 
days of age, 2h after 
infection with 3x109 
CFU Escherichia coli 
(O149:K91:F4ac) 
Weanling piglets, 
28 days of age 
No differences in 
performance, reduced 
incidence of diarrhea 
with single dose of 
3x1010 CFU L. 
plantarum after 
infection with E. coli 
Pieper et al. 2010 
Reuteran and levan (10 
g/L) produced by L. 
reuteri TMW 1.656 and 
LHT5794 
 Weanling gilts 
(n=6), 5-6 weeks 
of age, challenged 
with ETEC K88 
Tendency for reduced 
number of adhering 
ETEC K88 bacteria to 
the mucosa of 
intestinal segments 
infused with ETEC  
Chen et al. 2014 
Lactulose (10 g/kg) and 
Lactobacillus plantarum 
JC1  
2x1010 CFU/day Weanling piglets, 
app. 25 days old 
No effect of the 
treatments on diarrhea 
Guerra-Ordaz et 
al., 2014 
E. coli UM-7 and UM-2 
and raw potato starch (C: 
control, RPS: only raw 
potato starch, PRO: only 
E. coli probiotic, PRO-
RPS: E. coli probiotic 
and RPS) 
 Weanling pigs 
(n=40), 17 days 
old, challenged 
with E. coli K88 
Lowest number of E. 
coli in PRO and PRO-
RPS 
Krause et al., 
2010 
Fermented feed with L. 
reuteri TMW 1.656 and 
LHT5794 
 Castrated male 
pigs (n=36) (no 
challenge) 
No development of 
diarrhea – all pigs 
remained healthy 
Yang et al., 2015b 
 
 
